- Home
- AVY vs BAX Comparison
AVY vs BAX Comparison
Compare AVY & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVY
- BAX
- Stock Information
- Founded
- AVY 1935
- BAX 1931
- Country
- AVY United States
- BAX United States
- Employees
- AVY N/A
- BAX N/A
- Industry
- AVY Containers/Packaging
- BAX Medical/Dental Instruments
- Sector
- AVY Consumer Discretionary
- BAX Health Care
- Exchange
- AVY Nasdaq
- BAX Nasdaq
- Market Cap
- AVY 14.4B
- BAX 15.6B
- IPO Year
- AVY N/A
- BAX N/A
- Fundamental
- Price
- AVY $179.81
- BAX $30.09
- Analyst Decision
- AVY Buy
- BAX Buy
- Analyst Count
- AVY 11
- BAX 8
- Target Price
- AVY $206.05
- BAX $37.25
- AVG Volume (30 Days)
- AVY 635.7K
- BAX 3.4M
- Earning Date
- AVY 07-22-2025
- BAX 05-01-2025
- Dividend Yield
- AVY 2.09%
- BAX 2.26%
- EPS Growth
- AVY 27.06
- BAX N/A
- EPS
- AVY 8.69
- BAX N/A
- Revenue
- AVY $8,752,700,000.00
- BAX $10,771,000,000.00
- Revenue This Year
- AVY $2.08
- BAX $8.06
- Revenue Next Year
- AVY $3.97
- BAX $4.19
- P/E Ratio
- AVY $20.27
- BAX N/A
- Revenue Growth
- AVY 3.58
- BAX 15.36
- 52 Week Low
- AVY $157.00
- BAX $26.25
- 52 Week High
- AVY $233.48
- BAX $40.49
- Technical
- Relative Strength Index (RSI)
- AVY 53.61
- BAX 46.01
- Support Level
- AVY $173.64
- BAX $29.72
- Resistance Level
- AVY $181.63
- BAX $31.04
- Average True Range (ATR)
- AVY 3.01
- BAX 0.74
- MACD
- AVY -0.41
- BAX -0.10
- Stochastic Oscillator
- AVY 58.12
- BAX 36.66
About AVY Avery Dennison Corporation
Avery Dennison manufactures pressure-sensitive materials, merchandise tags, and labels. The company also runs a specialty converting business that produces radio-frequency identification, or RFID, inlays and labels. Avery Dennison draws a significant amount of revenue from outside the United States, with international operations accounting for the majority of total sales.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.